These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31481764)

  • 1. Inhibition of Mycobacterium abscessus, M. chelonae, and M. fortuitum biofilms by Methylobacterium sp.
    García-Coca M; Rodríguez-Sevilla G; Pérez-Domingo A; Aguilera-Correa JJ; Esteban J; Muñoz-Egea MC
    J Antibiot (Tokyo); 2020 Jan; 73(1):40-47. PubMed ID: 31481764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium,
    Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y
    Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum.
    Hall-Stoodley L; Lappin-Scott H
    FEMS Microbiol Lett; 1998 Nov; 168(1):77-84. PubMed ID: 9812366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of biofilm formation by rapidly and slowly growing nontuberculous mycobacteria.
    Williams MM; Yakrus MA; Arduino MJ; Cooksey RC; Crane CB; Banerjee SN; Hilborn ED; Donlan RM
    Appl Environ Microbiol; 2009 Apr; 75(7):2091-8. PubMed ID: 19201956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation among human, veterinary and environmental Mycobacterium chelonae-abscessus complex isolates observed using core genome phylogenomic analysis, targeted gene comparison, and anti-microbial susceptibility patterns.
    Fogelson SB; Camus AC; Lorenz WW; Vasireddy R; Vasireddy S; Smith T; Brown-Elliott BA; Wallace RJ; Hasan NA; Reischl U; Sanchez S
    PLoS One; 2019; 14(3):e0214274. PubMed ID: 30908517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
    BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov.
    Kusunoki S; Ezaki T
    Int J Syst Bacteriol; 1992 Apr; 42(2):240-5. PubMed ID: 1581184
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shoen C; Benaroch D; Sklaney M; Cynamon M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact Effect of a
    Pradal I; Esteban J; Mediero A; García-Coca M; Aguilera-Correa JJ
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32756304
    [No Abstract]   [Full Text] [Related]  

  • 11. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium fortuitum and Mycobacterium chelonae biofilm formation under high and low nutrient conditions.
    Hall-Stoodley L; Keevil CW; Lappin-Scott HM
    J Appl Microbiol; 1998 Dec; 85 Suppl 1():60S-69S. PubMed ID: 21182694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C; Gurpinar T; Ecemis T
    New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Esteban J; García-Coca M
    Front Microbiol; 2017; 8():2651. PubMed ID: 29403446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode.
    Marini E; Di Giulio M; Ginestra G; Magi G; Di Lodovico S; Marino A; Facinelli B; Cellini L; Nostro A
    PLoS One; 2019; 14(7):e0219038. PubMed ID: 31260476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.
    Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C
    Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002.
    Huang TS; Lee SS; Hsueh PR; Tsai HC; Chen YS; Wann SR; Leu HS; Ko WC; Yan JJ; Yuan SZ; Chang FY; Lu JJ; Wang JH; Wang HK; Liu YC
    J Formos Med Assoc; 2008 Apr; 107(4):281-7. PubMed ID: 18445541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm formation and biocide susceptibility testing of Mycobacterium fortuitum and Mycobacterium marinum.
    Bardouniotis E; Ceri H; Olson ME
    Curr Microbiol; 2003 Jan; 46(1):28-32. PubMed ID: 12432460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Treatment Provides a Competitive Advantage to Mycobacterium abscessus in a Dual-Species Biofilm with Pseudomonas aeruginosa.
    Rodríguez-Sevilla G; Crabbé A; García-Coca M; Aguilera-Correa JJ; Esteban J; Pérez-Jorge C
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.